Press Releases
Benzinga Professional
- 8:51 AM Rexnord Corporation Reports Q4 EPS of $0.32 vs $0.31 Est; Revenue of $540.30M vs $542.80M Est
- 8:48 AM First Potomac Realty Trust Prices 6.5M Shares at $14.70/Share, Up from Initial 6M Share Offering
- 08:48 AM AMAG Pharma Says Ferumoxytol Treatment Produced Significant Hemoglobin
- 8:44 AM Bristol-Myers CFO Speaking at UBS Global Healthcare Conference Says Committed to 3% Boost in 2013 Dividend
- 8:43 AM Macquarie Upgrades American Tower Corporation (REIT) to Outperform, Raises PT to $96.00
- 8:43 AM GreenHunter Energy Reports Prelim. Q1 Loss of $0.28-0.34/Share, Results Include Impairments $2.28M, $2.97M
- 08:43 AM UPDATE: Barrington Downgrades DENTSPLY to Market Perform Awaiting More Attractive Entry Point
- 08:43 AM UPDATE: Barrington Downgrades VCA Antech to Market Perform Awaiting Pullback
- 8:43 AM Pac Crest Upgrades Spansion Inc to Outperform, Announces $17.00 PT
- 08:43 AM UPDATE: Barrington Downgrades Walgreen Company to Market Perform After Achieving Price Target
- 08:42 AM UPDATE: Barrington Downgrades Patterson Companies to Market Perform After Achieving Price Target
- 8:42 AM FBR Begins Self Tender Offer for Up to 1.25M Shares, Says Will Pay $22.50-23.50/Share
- 8:42 AM TCP Capital Prices 4.5M Shares at $15.63/Share
- 08:42 AM UPDATE: Barrington Raises PT on NuVaisve on Multiple Positive Factors
- 08:42 AM UPDATE: Barrington Downgrades Align Technology to Market Perform After Achieving Price Target
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations
- Benzinga's Top Pre-Market Losers
- UPDATE: Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening
- J&J's Janssen Announces Primary Efficacy, Safety Findings from Phase 3 Study of Simeprevir Once Daily
- Benzinga's Top Upgrades
- Benzinga's Top Pre-Market Gainers
- Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
- Benzinga's Top Downgrades
- UPDATE: AutoZone FQ3 Profit Up 6.8%
- UPDATE: Best Buy Posts Upbeat Q1 Profit
- iPad 5 Production to Rise in July After Spring Trial
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- Microsoft's Third Xbox to be Unveiled in 24 Hours
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- The 8 Possible Changes Tumblr Users Can Expect from the Yahoo Acquisition
- Websense Signs Definitive Agreement to be Acquired by Vista Equity Partners; Shareholders to Receive $24.75 per Share in Cash in Transaction Valued at Approximately $1 Billion
- UPDATE: Bank of America Raises PT on Tesla Motors Following Equity Offering Completion
- UPDATE: Nomura Downgrades SanDisk Corporation to Neutral as Stock Approaches Target
- Barron's Recap: Cues from Cooperman